Peer Review History

Original SubmissionDecember 27, 2021
Decision Letter - Jake Michael Pry, Editor

PONE-D-21-40725Learning important common data elements from shared study data: the All of Us program analysisPLOS ONE

Dear Dr. Mayer,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please see attached comments from two reviewers attached. While reviewer one confirms that the work is a valuable addition to the literature I would suggest focusing on addressing the feedback from reviewer two. We thank you for your time and hope that you choose to submit a revision given the reviews provided.

Please submit your revised manuscript by Mar 26 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Jake Michael Pry, PhD, MPH

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have examined the common data elements from the All of Us program data. The data is available at our project repository

https://github.com/lhncbc/CRI/tree/master/AoU/CDE

This publication is in a combination of present and past tense. Even though the All of US program maybe continuing to enroll participants, the data for this study was obtained at a specific timeline (late 2021), and the analyses performed retrospectively, and hence could be described in past tense.

Overall the paper is well written. Increased CDE usage in large studies like the All of Us program would better facilitate the usability of the data.

Reviewer #2: Summary

The authors analyze the All of US (AoU) program with respect to common data elements (CDEs) which are standardized across multiple clinical studies. AoU uses the OMOP Common Data Model for standardization. The authors investigate the frequency of CDEs as compared to unique data elements (UDEs), defined specifically for AoU. Among other details, the origin of the CDEs is described.

General

The manuscript deals with an important topic for the medical research infrastructure. I have a few comments but overall the manuscript merits publication.

Comments

1) Several typos and grammar errors. Please correct.

2) Abstract:

Abbreviation PPI not defined.

“originated from a previous data collection initiative, such as PhenX (17 CDEs) and PROMIS (15 CDEs)” plr: data collection initiatives

3) 2.1 All of Us program

Missing is the aim of the initiative and the planed follow-up. Is biomaterial collected by AoU? Is genetic data available? Please add.

4) The structures of the data elements and values are rather complex and not easy to grasp. Add figures which present the data structures and hierarchies and also add examples in the text.

5) Table 2: Why is the column “CRF” blank for some elements? Explain in legend to table 2.

6) Element ‘Current State’: Please explain what that means.

7) l 233: GROR: It is not explained what that is.

8) l 245: Brackets not consistent.

9) Table 6: Add the event counts. Why do the “Percent of Element Values” not add up to 100%? Please explain what the percent refers to. Please additionally use such a reference population that the percentages add up to 100%.

10) 5.1 EHR and research data integration:

“An example of this can be seen with cigarette smoking quantification (OMOP concept_id: 40766929) which may be established by research questionnaire (in 97.2% of instances) but later updated via EHR import (in 2.8% of instances).”

Discuss the possibility of bias because of the low follow-up percentages which might result in selective, biased information.

11) l. 388f: grammar error

12) 5.3 Types of CDEs:

Please illustrate the two axes and the number of elements contained in the four sets by a table or Venn diagram.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Dear Dr. Jake Michael Pry,

We thank you and the reviewers for the input and constructive comments on our manuscript. We have thoroughly reviewed each comment and our manuscript and have edited our paper taking into account each comment. We are now submitting the edited and improved version of our manuscript.

See below our response (in bold font) to each reviewer comment. Our response follows the reviewer’s comments (shown in regular un-bolded text).

Thank you,

Craig Mayer and Vojtech Huser

Reviewer #1

This publication is in a combination of present and past tense. Even though the All of US program maybe continuing to enroll participants, the data for this study was obtained at a specific timeline (late 2021), and the analyses performed retrospectively, and hence could be described in past tense.

Thank you for the comment. We have changed the portions where we discuss our analysis, results and conclusions, to conform to past tense. For the purposes of describing the All of Us program and their data collection practices we maintain the text in present tense since we are describing the ongoing methodology of the program itself. While our analysis and the results we found were done in the past and therefore in the past tense, the All of Us program is ongoing, and we feel should be described in present tense for that reason.

Reviewer #2

1) Several typos and grammar errors. Please correct.

Thank you for your comments. We have corrected typos and grammar mistakes throughout the manuscript.

2) Abstract:

Abbreviation PPI not defined.

We have defined PPI in the Abstract where the acronym first appears.

“originated from a previous data collection initiative, such as PhenX (17 CDEs) and PROMIS (15 CDEs)” plr: data collection initiatives

We have made the term data collection initiative plural in the text of the Abstract to conform with the multiple initiatives discussed.

3) 2.1 All of Us program

Missing is the aim of the initiative and the planed follow-up. Is biomaterial collected by AoU? Is genetic data available? Please add.

We added the aims and a brief description of additional data types. However, it would be out of scope to further discuss these data types and process as the manuscript is focused on CRF and EHR data and the presence of common data elements. The addition of these data types beyond just mentioning them do not contribute to the conclusions as they are not part of the common data model structure. The further details regarding the All of Us program was added to this section (2.1).

4) The structures of the data elements and values are rather complex and not easy to grasp. Add figures which present the data structures and hierarchies and also add examples in the text.

Figure 1 along with an explanation was added to section 3.2 to clarify this process and structure.

5) Table 2: Why is the column “CRF” blank for some elements? Explain in legend to table 2.

The reason the CRF column is blank for some data elements is that these elements originate from a research visit instead of a CRF. This explanation was added as a footer to Table 2.

6) Element ‘Current State’: Please explain what that means.

To avoid initial confusion about the meaning of this data element, it was removed from Table 2. When it is mentioned later in the text in section 4.1.1, we explain that ‘Current State’ refers to the geographic location of the participant.

7) l 233: GROR: It is not explained what that is.

We added an explanation of what GROR refers to in section4.1.2. The exact meaning of the GROR acronym is not made apparent by the All of Us program or OMOP terminology. Instead, we explained the general purpose of the GROR CRF.

8) l 245: Brackets not consistent.

We fixed this with the addition of a close bracket for bracket agreement.

9) Table 6: Add the event counts. Why do the “Percent of Element Values” not add up to 100%? Please explain what the percent refers to. Please additionally use such a reference population that the percentages add up to 100%.

Table 6 has been redone to include the count of total responses and responses by value chosen to describe the percentage. All values were included to see 100% of the population’s responses. A sentence was added before the table to explain the contents.

10) 5.1 EHR and research data integration:

“An example of this can be seen with cigarette smoking quantification (OMOP concept_id: 40766929) which may be established by research questionnaire (in 97.2% of instances) but later updated via EHR import (in 2.8% of instances).”

Discuss the possibility of bias because of the low follow-up percentages which might result in selective, biased information.

Sentences were added to section 5.1 to discuss this possibility. We have added sentences to this section describing the consideration of bias in the data due to the differences in population follow-up caused by the inclusion of EHR data instead of research process repetition.

11) l. 388f: grammar error

This sentence was edited to ensure proper grammar and clarify meaning.

12) 5.3 Types of CDEs:

Please illustrate the two axes and the number of elements contained in the four sets by a table or Venn diagram.

Table 9 was added to the section to better show this crossover and process. This should help clarify the premise described regarding the types of CDEs and the axes.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Jake Michael Pry, Editor

Learning important common data elements from shared study data: the All of Us program analysis

PONE-D-21-40725R1

Dear Dr. Mayer,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Jake Michael Pry, PhD, MPH

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Thank you for submitting to PLoS One, we hope that you will consider PLoS One for future work as well.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: All comments addressed. Overall the paper is well written. Increased CDE usage in large studies like the All of Us program would better facilitate the usability of the data.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Jake Michael Pry, Editor

PONE-D-21-40725R1

Learning important common data elements from shared study data: the All of Us program analysis

Dear Dr. Mayer:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Jake Michael Pry

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .